CASPOFUNGIN Mepha subst sèche 50 mg flac
7680672310015
CH-67231
J02AX04
08.06.0.
Active substances:
1 / 3
google
Details
- Product number
- 6723101
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- caspofunginum 50 mg ut caspofungini diacetas 55.52 mg, saccharum, mannitolum, acidum aceticum glaciale, natrii hydroxidum corresp. natrium 0.805 mg, pro vitro.
Articles (1)
Caspofungin-Mepha 50 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
caspofunginum
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
caspofungini diacetas
|
55.52 MG | Substance | WIZUS |
|
saccharum
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
natrium
|
0.805 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 331.10
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/08/2019
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 67231
- Drug name
- Caspofungin-Mepha, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- J02AX04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 08/03/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 08.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CASPOFUNGIN Mepha subst sèche 50 mg flac
- Description (DE)
- CASPOFUNGIN Mepha Trockensub 50 mg Durchstf
- Market launch
- 08/03/2019
- Narcotic (BTM)
- No